4//SEC Filing
Norwest Venture Partners XI, LP 4
Accession 0001209191-20-004714
CIK 0001636422other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:30 PM ET
Size
12.5 KB
Accession
0001209191-20-004714
Insider Transaction Report
Form 4
Crowe Jeffrey
10% Owner
Transactions
- Other
Common Stock
2020-01-21−600,000→ 2,352,090 total(indirect: By Partnership) - Other
Common Stock
2020-01-21−599,938→ 2,352,153 total
Norwest Venture Partners XI, LP
10% Owner
Transactions
- Other
Common Stock
2020-01-21−599,938→ 2,352,153 total - Other
Common Stock
2020-01-21−600,000→ 2,352,090 total(indirect: By Partnership)
Kossow Jon Erik
10% Owner
Transactions
- Other
Common Stock
2020-01-21−599,938→ 2,352,153 total - Other
Common Stock
2020-01-21−600,000→ 2,352,090 total(indirect: By Partnership)
Norwest Venture Partners XII, LP
10% Owner
Transactions
- Other
Common Stock
2020-01-21−599,938→ 2,352,153 total - Other
Common Stock
2020-01-21−600,000→ 2,352,090 total(indirect: By Partnership)
Footnotes (4)
- [F1]Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP ("NVP XI") to its limited partners.
- [F2]The NVP XI distribution resulted in a change in the form of beneficial ownership so that following the distribution 62 shares were beneficially owned by Kossow Family Trust, of which Mr. Kossow is a Trustee. The remaining 2,352,091 shares are held of record by NVP XI. Genesis VC Partners XI, LLC ("Genesis XI") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC ("NVP Associates"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
- [F3]Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP ("NVP XII") to its limited partners.
- [F4]The securities shown on Line 2 of Table I represent securities held of record by NVP XII. Genesis VC Partners XII, LLC ("Genesis XII") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001534522
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:30 PM ET
- Size
- 12.5 KB